PRC2-independent EZH2-mediated transcriptional activation was previously reported in prostate cancer and B-cell lymphoma through collaboration with transcriptional activators like E2F1 [71, 72]. Here, EZH2 is linked to B-cell non-Hodgkin lymphoma.